Stanford
Yesterday was Christmas eve and we had a bonus post, but we have more: a great 52-minute video with Carlos Brito, CEO of AB-InBev, on High-Performance Culture. It’s very interesting to note that the “speech” doesn’t really change over the years – but why should it change? The “recipe” of Dream, People, Culture resonates well and in their case has been implemented with so much discipline and energy that they have achieved huge success over +20 years in the brewing business (even longer than that if you count the Banco Garantia golden age).
Read more about Christmas bonus, pt. 2: Carlos Brito @ Stanford
Stanford U. is starting a program to advocate against the influence of drug and medical device cies. on physicians, a practice that spins some US$1 billion per year. The problem is that the program is being partly funded by Pfizer. Stanford claims that Pfizer’s support was 100% voluntary and that there are no strings attached. How far can we push the boundaries on conflicts of interest? And if it appears conflicted, doesn’t it defeat the purpose from the get-go?
